Ali Tabatabaei - Concepedia

Author

Ali Tabatabaei

Acadia Pharmaceuticals (United States)

Also Known As

A Tabatabaei, Ali R. Tabatabaei, Ali Tabatabaei, Tabatabaei, Ali, Tabatabaei, Ali Reza

Publications

Citations

H-Index

Concepts

All Affiliations

Acadia Pharmaceuticals (United States)University of British Columbia Dart NeuroScience (United States)Scripps Institution of Oceanography Scripps (United States)

About

Ali Tabatabaei is an author at Acadia Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	362
2	Natural Sciences	4	4	201
3	Health Sciences	1	1	67
4	Social Sciences	1	1	44
5	Allergy	1	1	20

Ali Tabatabaei

Publications

970

Citations

H-Index

Page 1

	Year	Citations
Comparison of in Vitro P-Glycoprotein Screening Assays: Recommendations for Their Use in Drug Discovery Dietmar Schwab, Holger Fischer, Ali Tabatabaei, Journal of Medicinal Chemistry	2003	200
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons, Nature Molecular RecognitionBiochemistryNatural SciencesEnzyme CatalysisMolecular Biology	2024	88
AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model Stefania Risso Bradley, Jelveh Lameh, Linda Ohrmund, Neuropharmacology Molecular PharmacologyCognitive PerformanceFunctional SelectivityMedicinePhysiology	2009	67
ACP-103, a 5-Hydroxytryptamine 2A Receptor Inverse Agonist, Improves the Antipsychotic Efficacy and Side-Effect Profile of Haloperidol and Risperidone in Experimental Models Luis R. Gardell, Kimberly E. Vanover, Linda Pounds, Journal of Pharmacology and Experimental Therapeutics	2007	57
Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties Brian Dyck, Bryan J. Branstetter, Tawfik Gharbaoui, Journal of Medicinal Chemistry	2017	54
Design and Synthesis of Novel and Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders Laurent Gomez, Mark E. Massari, Troy Vickers, Journal of Medicinal Chemistry Psychotropic MedicationPharmacotherapyChemical BiologyPharmaceutical ChemistryRat Model	2017	52
Identification and Characterization of Novel Small-Molecule Protease-Activated Receptor 2 Agonists Luis R. Gardell, Jian-Nong Ma, Jimmi Gerner Seitzberg, Journal of Pharmacology and Experimental Therapeutics	2008	51
Assessing the Mechanism of Metabolism-Dependent Valproic Acid-Induced in Vitro Cytotoxicity Ali Tabatabaei, Frank S. Abbott Chemical Research in Toxicology Antioxidant EnzymesRedox BiologyToxicological MechanismOxidative StressToxicology	1999	51
Characterization of Highly Efficacious Allosteric Agonists of the Human Calcium-Sensing Receptor Jian-Nong Ma, Michelle Owens, Magnus Gustafsson, Journal of Pharmacology and Experimental Therapeutics	2011	49
Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice Ali Tabatabaei, Thomas L. Perry, Shirley Hansen, Neuroscience Letters Striatal DopamineMedicinePsychopharmacologyNeuropharmacologyPartial Protective Effect	1992	44

Page 1